GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verrica Pharmaceuticals Inc (FRA:1NE) » Definitions » Pretax Margin %

Verrica Pharmaceuticals (FRA:1NE) Pretax Margin % : 1,283.30% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Verrica Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Verrica Pharmaceuticals's Pre-Tax Income for the three months ended in Sep. 2024 was €-20.60 Mil. Verrica Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was €-1.61 Mil. Therefore, Verrica Pharmaceuticals's pretax margin for the quarter that ended in Sep. 2024 was 1,283.30%.

The historical rank and industry rank for Verrica Pharmaceuticals's Pretax Margin % or its related term are showing as below:

FRA:1NE' s Pretax Margin % Range Over the Past 10 Years
Min: -1307.47   Med: -292.33   Max: -271.11
Current: -922.81


FRA:1NE's Pretax Margin % is ranked worse than
72.29% of 1014 companies
in the Biotechnology industry
Industry Median: -150.165 vs FRA:1NE: -922.81

Verrica Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for Verrica Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verrica Pharmaceuticals Pretax Margin % Chart

Verrica Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial - - -292.34 -271.12 -1,307.38

Verrica Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -850.31 -1,238.12 -531.39 -332.00 1,283.30

Competitive Comparison of Verrica Pharmaceuticals's Pretax Margin %

For the Biotechnology subindustry, Verrica Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verrica Pharmaceuticals's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verrica Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Verrica Pharmaceuticals's Pretax Margin % falls into.



Verrica Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Verrica Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-61.434/4.699
=-1,307.38 %

Verrica Pharmaceuticals's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-20.597/-1.605
=1,283.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verrica Pharmaceuticals  (FRA:1NE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Verrica Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Verrica Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Verrica Pharmaceuticals Business Description

Traded in Other Exchanges
Address
44 West Gay Street, Suite 400, West Chester, PA, USA, 19380
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals Headlines

No Headlines